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The role/need for estrogen in regulating testicular function of adult male bonnet monkeys (M. radiata) has
been investigated by dosing orally a group of five normal males 2.5 mgs of CGP 47645, a long-acting
nonsteroidal aromatase inhibitor (AI), once every 5 days for over 150 days. Such treatment resulted in a
10-fold increment in nocturnal serum testosterone (T) levels, which were sustained for 85 days of treatment,
and a twofold increment in basal serum T levels was present throughout the 150 days of treatment. Analysis
of ejaculated semen showed a marked reduction (;90%) in sperm counts in four out of five monkeys between
Days 55–85 of treatment. During this period, the motility score also was markedly reduced from a normal
score of 3-5 to 0-2. Flow cytometric analysis of testicular germ cells obtained from biopsy tissue taken on
Days 63 and 120 indicated a marked reduction only in elongating/elongated spermatid population (com-
pared to Day 0 values), suggesting inhibition in spermiogenic process. Epididymal sperm maturation also
seemed effected as sperm chromatin, on flow cytometric analysis for decondensability following exposure to
5 mM dithiotreitol, showed to be in a hypercondensed state. This study thus indicates that estrogen has an
important role in providing normal testicular and sperm function in the primate. (Steroids 63:414–420,
1998) © 1998 by Elsevier Science Inc.
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Introduction
The ability of estrogen, a well-defined female hormone, to
act as a feedback regulator of gonadotropins in both the
female and male mammal is well known. The physiological
role of estrogen in regulating testicular function, however,
appears ill understood, and this perhaps is due to relatively
low amounts of estrogen produced by the male as compared
to the female. Although earlier studies led to the assertion
that estrogen is synthesized by Leydig cells in adults and by
Sertoli cells in prepubertal males1–6 there are also reports
indicating that the seminiferous epithelium of the adult
animal is capable of estrogen synthesis.7 Germ cells8 as well
as placental tissue9 are also known to exhibit P-450 aro-
matase activity. Some of the recent studies involving the
blockade of estrogen action by follicle regulatory proteins in
male rats and dogs10–12 and insertional disruption of estro-
gen receptor genes in rodents13,14 have indicated that estro-
gen may be required for normal testicular function in the
male. In addition, the presence of estrogen receptors in the
epididymis15–17 suggests a positive role for estrogen in
sperm maturation.
Blockade of estrogen synthesis by specific aromatase
inhibitors (AIs) is one of the best ways of studying estrogen
action in vivo. Treatment with AI has been shown to en-
hance luteinizing hormone (LH) and testosterone (T) secre-
tion in the human male18,19 and cynomolgus monkeys,20 a
positive feedback effect of estrogen deprival. In the present
study, in bonnet monkeys (M. radiata) a new generation
nonsteroidal aromatase inhibitor of high specific activity,
CGP 47645 [a fluoridated analog of Letrozole (CGS
20267), a much more widely studied AI] has been used to
investigate the effect of blocking estrogen synthesis on
testicular testosterone as well as sperm production. The
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results of our study, we believe, provide a better understand-
ing of the physiological role of estrogen in regulating fer-
tility in the male primate.
Experimental
Hormones and chemicals
The ovine luteinizing hormone (oLH) used was a laboratory prep-
aration, with 1 ng of this material exhibiting an activity profile
equivalent to 0.133 ng NIH-hLH (AFP-4745B) in the radio recep-
tor assay. Tritiated T (97 ci/m mol) was purchased from Amer-
sham, UK. Aromatase inhibitor CGP47645 was donated by CIBA
Geigy Ltd, Basel, Switzerland. Dithiotreitol (DTT), ethidium bro-
mide (EB), RNase, and Nonidet P-40 were from Sigma, St Louis,
MO, USA. Papain and Dulbecco’s phosphate buffered saline
(DPBS) were obtained from Himedia, Bombay, India.
General methodology
Five healthy adult male bonnet monkeys ages 8–12 years weigh-
ing 7–9 kg each screened for normal diurnal T rhythms and
spermatogenesis (by DNA flow cytometry using testicular tissue
obtained by needle biopsy as well as semenology) were used for
the study. The general care and maintenance of monkeys under
conditions of controlled photo period (12L:12D) has been de-
scribed earlier.21 The present study was cleared by institutional
ethical committee for use of non-human primates for biomedical
research.
Treatment
A dose of 2.5 mg of CGP 47645 dissolved in 2.5 mL of ethanol
was given by oral route (by means of a dropper) once every 5 days.
This dose of AI was arrived at by determining the estrogen
synthesis inhibiting efficacy as well as the duration of the effect of
a single dose of the drug in appropriate rat and female monkey test
systems.22,23 Oral administration of 50 mg of CGP 47645 to
immature rats totally blocked the PMSG-induced increase in the
uterine weight for a minimum of 6 days. A single oral adminis-
tration of CGP 47645 (2.5 mg) to female monkeys on Day 7 of the
cycle prevented estrogen levels increasing from a basal of ,80
pg/mL for the following 6 days. Normally, estrogen levels between
Days 8–9 of the cycle range between 200–600 pg/mL. In addition,
the administration of a single oral dose of CGP 47645 (4 mg/
monkey) to adult male monkeys resulted in serum testosterone
being elevated over the control values for the succeeding 12 days;
maximal increment, however, was achieved by the sixth day of
administration.23 On the basis of these observations and consider-
ing that the production of estrogen in the male compared to the
female is low, it was assumed that oral administration of 2.5 mg of
CGP 47645 to adult males should be adequate to block the aro-
matase activity for a minimum of 5 days.
Blood sampling and testosterone assay
Blood samples were collected from unanesthetized monkeys by
way of femoral vein/arterial puncture using sterile vacutainer tubes
(Becton-Dickinson, New Jersey, USA) at 10.00 and 20.00 h of the
day and represented a.m. and p.m. values. The sera was separated
within 12 h and stored at 220°C until analysis.
Testosterone was analyzed by a specific radioimmunoassay
described in detail earlier24 using ether extracted serum samples.
The sensitivity of the assay was 10 pg/tube, and the inter and
intra-assay coefficients of variation were 9.8% and 8.3%, respec-
tively. The aliquot of serum sample used for assay varied depend-
ing upon whether T was being measured in a.m. or p.m. samples
of control and AI-treated monkeys.
Quantitation of testicular germ cells by DNA
flow cytometry
Testicular needle biopsy was performed under ketamine anaesthe-
sia as described earlier.25 Preparation of single-cell suspension of
testicular germ cells26,27 and the procedure adapted for pepsiniza-
tion and DNA staining of ethanol fixed cells with ethidium bro-
mide have been described earlier.27,28 The flow cytometric analy-
sis of stained germ cells was carried out using a FACScan (Becton-
Dickinson, San Jones, CA, USA) flow cytometer equipped with an
argon ion laser. At least 10,000 cells per sample were acquired and
analysed using the LYSIS II software program (Becton-
Dickinson). The germ cell distribution pattern (using leukocytes as
internal diploid marker) showed four distinct cell populations
based on DNA content—spermatogonia (2C), the cells in synthetic
phase and primary spermatocytes (4C), round spermatids (1C), and
elongating/elongated spermatids (HC). It was, however, possible
to apply electronic gating to differentiate between elongating
(HC1) and elongated (HC2) spermatids. The germ cell transfor-
mation ratios were calculated from % cell populations.
Ejaculated sperm samples from treated and control animals
were decondensed by treating with DTT, the chromatin exposed to
ethidium bromide and flow cytometrically analysed as described
earlier.29 The DTT treatment brought about reduction of free thiol
groups in the protamine.
Seminal parameters
Semen samples collected at 10- to 15-day intervals by electro-
ejaculation were analyzed for sperm count and motility according
to the procedure described in the WHO manual 1992.30
Statistical analysis
All data are expressed as mean 6 SEM. Significance of differ-
ences between T levels, testicular germ cell percentages, and
seminal parameters during pretreatment and treatment phase were
analyzed by Student’s t test.
Results
Effect of CGP 47645 on serum T profile of adult
male monkeys
Oral administration of CGP 47645 at a dose of 2.5 mg once
in 5 days over a period of 85 days resulted in a significant
and sustained increment (approximately 10-fold increase in
the basal and 5-fold increase in nocturnal values) in serum
T levels. However, the high levels of serum T could not be
maintained beyond 85 days of treatment, the nocturnal high
levels reaching normal values by Day 180 of continued
treatment. The basal levels of T all the same continued to be
significantly high (p , 0.05) for the entire period of 180
days (Figure 1).
Effects of AI treatment on seminal parameters
Sperm count of four out of five treated monkeys was mark-
edly reduced between Days 55–85 of treatment. At time
points beyond this, the reduction in the sperm count of
individual animals was not significant at consecutive time
points, although the average counts did not revert back to
Estrogen and testicular function in primate: Shetty et al.
Steroids, 1998, vol. 63, July/August 415
pretreatment value (Figure 2a). All five monkeys showed
marked reduction in sperm motility, and the fertility index
of these monkeys (sperm count 3 motility) was reduced
from a Day 0 value of 870.2 6 180.5 to 5.2 6 2.62 (p ,
0.0007) between Day 55 to 95 of treatment (Figure 2b). The
variation in sperm counts of a group of control monkeys
analysed over the same time period was within 10% of Day
0 value.
Effect of blocking estrogen synthesis on
spermatogenesis
DNA flow cytometric analysis of germ cells processed from
testicular biopsy tissue taken on Day 0, 63, and 120 of
treatment showed that there was no significant change in the
relative population of spermatogonia (2C), primary sper-
matocytes (4C), and cells in synthetic phase (S-ph; Table 1).
However, from the composite flowcytogram of the sperma-
tid population obtained, it was evident that estrogen depri-
vation effected spermiogenesis (Figure 3). The transforma-
tion of round to elongating spermatids (HC1:1C) was
inhibited by 47 and 53% by Days 63 and 120 of treatment,
respectively. The elongated spermatid population (HC2)
was reduced at Days 63 and 120 by 43 and 81%, respec-
tively (p , 0.001), and the transformation of round to
elongated spermatid (HC2:1C) population at the above two
time points appeared reduced by 15 and 88%, respectively.
The overall HC1 1 HC2:1C ratio changed from a normal of
1.11 (pretreatment value) to 0.78 by Days 63 and to 0.32 by
Day 120 of treatment (Table 1), suggesting thereby that the
lack of estrogen affects spermiogenesis specifically (trans-
formation of round to elongating and elongated spermatids).
In vivo response of AI-treated monkeys to oLH
To better understand the functionality of Leydig cells in the
AI-treated animals, the acute in vivo response of these
monkeys to a bolus i.v. injection of oLH (1 mg) was
determined. The results showed that the responsivity of the
AI-treated monkeys (n 5 2) as compared to the controls
(n 5 2) was twofold higher in terms of serum T production
(Figure 4).
Susceptibility of ejaculated sperms of control and
AI-treated monkeys to DDT-induced decondensation
Flow cytometric analysis showed that whereas sperm chro-
matin of control monkeys exhibit maximal decondensation
when exposed to DTT concentrations of 5 mM and higher,
sperm of AI-treated monkeys showed significant reduction
(p , 0.002) in decondensability even at 20 mM DTT
(Figure 5).
Discussion
It is well recognized that in the primate as in other
mammals testicular testosterone production is under LH
control.24 Testosterone has long been held as the primary
feedback regulator of LH in mammals. AI is expected to
block estrogen synthesis not only in major steroid-
producing organs like the testis and adrenal but also in
other tissues, such as the hypothalamo–pituitary–axis
Figure 2 Sperm count and fertility index (a product of counts
per million 3 motility score) of experimental monkeys during
pretreatment and AI treatment period. A, the mean and individ-
ual sperm count values of five monkeys at different days of
treatment. B, the fertility index (mean 6 SEM) at different times
of the experiment (n 5 5) is shown. For further details of
experimental procedure, see text.
Figure 1 Serum testosterone profile in a group
of five adult male bonnet monkeys chronically
treated with a long-acting AI. The AI (CGP
47645) was administered orally at a dose of 2.5
mg once every 5 days. The range of normal
serum testosterone values in a group of control
monkeys (n 5 5) at 1000 h (a.m. values) and
2000 h (p.m. values) is represented by hatched
and dotted areas, respectively.
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placenta. Its use in the current study clearly establishes
that it is estrogen rather than T that acts as the primary
feedback regulator of gonadotropins (and as such T pro-
duction) in the male primate. This is in agreement with
earlier studies in primates (References 18 –20 and 31–
33). In rodents aromatization also is known to be essen-
tial for androgen-regulated feedback control of gonado-
tropins.34 Deprivation of estrogen by using a nonsteroidal
AI (CGS 16949A), however, results in an increase in LH
level in the female35 but not in the male rat (Reference
18, Shetty et al., unpublished data). The above observa-
tions also correlate with the recent observations in male
mice14 in which estrogen action was compromised by
targeted disruption of estrogen receptor gene. The repeat
administration of the drug as carried out in the current
monkey study could, by continuously inhibiting aro-
matase activity at the hypothalamo–pituitary axis, result
in an increase in endogenous-circulating LH levels lead-
ing to a significant increase in serum T. The inability of
the drug to maintain nocturnal serum T levels at supra-
physiological levels beyond Day 90, however, seems
currently unexplainable. In an attempt to determine
whether this is due to Leydig cells becoming desensitized
to continuous stimulation by endogenous LH (perhaps as
a consequence of lifting of feed back inhibition), mon-
keys were challenged on Day 166 of drug treatment with
a bolus injection of oLH. The results showed that there
was a good response to the bolus, in fact a response better
than that provided by controls. This experiment all the
same does not overrule completely the setting in of
desensitization as we have observed earlier that the mon-
key testis could be desensitized to the action of a rela-
tively lower level of endogenous LH administered sev-
eral hours before a bolus injection of LH. These
monkeys, although exhibiting a blockade of naturally
occurring nocturnal testosterone surges, do respond to a
bolus injection of LH by producing high T levels.36
Alternately it is possible that following continuous ex-
posure to the drug the monkeys have developed newer
metabolic clearance pathways for the drug resulting in its
rapid clearance. The AI used here, CGP 47645, is known
to have a relatively longer half-life than CGS 20267 and
CGS 16949A.23 Treatment of dogs with the AIs
CGP3249 and CGS 20267 has been suggested to cause
hypertrophy and hyperplasia of testicular Leydig cells.37
Furthermore, estrogen produced by germ cells has been
suggested to have a regulatory influence on androgen
production through a negative feedback affect on Leydig
cells.8
The current study has shown that the blockage of
estrogen synthesis leads to compromise only in spermio-
genesis and not spermatocytogenesis. Besides, the func-
tional ability of sperm produced during Day 40 –120 of
treatment also seemed impaired. The flow cytometric
analysis of germ cells indicated significant reduction in
elongating/elongated population of spermatids between
Days 60 to 120 of treatment, and this may be the reason
for observing a marked reduction in sperm count during
the early period of drug treatment. An additional param-
eter of defective spermiogenesis and sperm maturation
was the observation that sperm motility was markedly
Figure 3 A typical flow cytogram of an aromatase inhibitor-
treated adult male monkey showing the effect on spermatid
population. The numbers 0, 60, and 120 under each curve refer
to days of treatment. The symbols 1C, HC1, and HC2 refer to
round, elongating, and elongated spermatid population, respec-
tively.
Table 1 Germ Cell Distribution Pattern in Monkeys Treated with AI, CGP 47645 on a Continuous Basis
Day of
treatment
Spermatogonia
2C
S-ph cells
in S-phase
Primary
spermatocytes
4C
Round
spermatids
1C
Elongating
spermatids
HC1
Elongated
spermatids
HC2 HC1:1C HC2:1C
0 12.72 6 1.40 2.41 6 0.20 7.87 6 1.40 31.74 6 0.30 16.26 6 3.20 19.11 6 0.60 0.51 0.60
63 11.29 6 1.00 1.90 6 0.30 7.15 6 2.20 21.31 6 0.30* 5.91 6 3.40† 10.91 6 0.50* 0.27 0.51
120 11.62 6 2.00 2.78 6 0.40 6.46 6 0.90 52.57 6 0.90* 12.96 6 3.70 3.66 6 2.10* 0.24 0.07
Mean 6 SEM.
n 5 5.
Significantly different from Day 0 value: *p , 0.0001; †p , 0.05.
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reduced (a score of 0-2) in the treatment group compared
to a score of 3-5 in the control group of monkeys, and this
led to significant lowering of calculated fertility index (a
product of motility score and sperm counts). Monkeys
exhibiting fertility index below 500 have been observed
by us earlier to be infertile.38
The reduction in motility and concentration of sperms
caused due to lack of estrogen may be due to more than
one reason. Estrogen receptors are known to be present in
sertoli cells39 as well as epididymis.17 In addition, the
presence of P450 aromatase in germ cells (relatively
more in spermatid than pachytene spermatocytes) of ro-
dents has been reported.8 It has been hypothesized that
estrogen produced by the germ cells may have a role in
gene expression of spermatogenic or epithelial cell func-
tion in epididymis.8,14 This suggests that changes in
sperm motility and concentration in AI-treated monkeys
may be caused by the loss of estrogen action in Sertoli as
well as germ cells. Improper or poor maturation of sperm
during epididymal transit due to estrogen lack could be
the cause of observed hypercondensation of sperms of
AI-treated monkeys. This was of particular interest to us
as we recently reported that vulnerability to DTT-induced
decondensation of monkey sperms markedly increases
following specific follicle-stimulating hormone depriva-
tion.40,41 Interestingly, both hyper- and hypocondensation
of ejaculated sperms have been correlated with infertili-
ty.42 In rodents, the blockage of estrogen action either by
using aromatase inhibitors13,14 or by the disruption of
estrogen receptors13,14 has been shown to impair fertility
in general. Evidence indicating impairment in testicular
function such as atrophy of interstitial cells,37 disruption
of seminiferous epithelial function,11,14 reduced sperm
function,14 and sexual activity14,43,44 following the block-
age of estrogen function has also been reported. In con-
clusion, by observing that a specific lack of estrogen lack
in adult male monkeys leads to defective spermiogenesis,
which is accompanied by marked reduction in the quality
and quantum of sperm produced, we tend to believe that
Figure 5 Effect of AI treatment on DTT-induced decondensa-
tion of sperm DNA. Ethidium bromide bound fluorescence
(mean 6 SEM) of control (E; n 5 5) and AI-treated (F; n 5 4)
sperms following exposure to different concentrations of DTT.
Figure 4 Testicular responsiveness of control -E- (n 5 2) and AI treated -F- (n 5 2) monkeys to a bolus injection of oLH (1 mg injected
i.v.). Serum testosterone (T) levels before and following oLH injection are depicted.
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estrogen could play a crucial role in regulating fertility in
the male primate.
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